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1. Introduction 
Substance use disorders are expressed within most age, economic, cultural, gender, and 
occupational groupings. They come to expression in individuals who may be considered 
vulnerable on biological, psychological, social, family, or spiritual levels. As with other 
mental disorders, vulnerability differs between individuals with both nature and nurture 
influencing their risk. Some health care professionals will also develop these chronic 
disorders regardless of any special knowledge or experience they may have. When 
substance use disorders are expressed within the health care professions, the delivery of 
safe, competent, compassionate, and ethical care is threatened. The health of the health care 
professional is also at risk as the substance use disorders typically progress in severity and 
may result in premature death. 
This is often a sensitive issue to address yet its importance demands the concerted attention 
of the health care professions. The following chapter begins with background on the issue of 
substance use disorders within the health care professions, followed by a discussion of 
mitigating associated risks, and an exploration of disciplinary and alternative to discipline 
policies. This chapter is focused primarily on literature on physicians and nurses because of 
the predominance of research in these disciplines. The argument will be made that creating 
conditions that encourage early identification, reduce barriers to treatment, and that include 
long-term monitoring programs provide the best conditions for ameliorating the risks 
resulting from substance use disorders amongst the health care professions to patient safety 
and health care professional health. 
2. Background 
It has been argued that the substance use disorders are the most important illnesses of our 
time because they are the most prevalent mental disorder, the leading preventable cause of 
death and disease, and the single greatest contributor to excess health care spending (Els, 
2007). Their scope is widespread as they affect the health and wellbeing of individuals, 
families, and society at large. The substance use disorders are a leading occupation health 
issue, ranking second as the cause of disability, and affect individuals predominantly in 
their prime working years. 
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The substance use disorders are chronic, progressive, and potentially fatal illnesses that are 
recognized by both the major disease classification systems as bona fide, chronic and 
relapsing medical conditions (American Psychiatric Association [APA], 2000; World Health 
Organization [WHO], 2007). Research has demonstrated that repeated exposure to 
substances over time might alter brain structure, chemistry, and function in susceptible 
individuals. The American Psychiatric Association’s [APA](2000) Diagnostic and Statistical 
Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR) classification of Substance 
Use Disorders includes the disorders of Substance Dependence and Substance Abuse.  
Substance Dependence is described as the continued use of a substance despite significant 
substance-related problems and a pattern of repeated self-administration that can result in 
tolerance, withdrawal, and compulsive drug-taking behaviour. Craving, defined as a strong 
desire to use the substance, is experienced by most individuals. Substance dependence as 
characterized by a maladaptive pattern of substance use, leading to clinically significant 
impairment or distress, and manifested by three (or more) of the following occurring at any 
time in the same 12-month period:  
• Tolerance as defined by either of the a need for markedly increased amounts of the 
substance to achieve intoxication or desired effect, or markedly diminished effect with 
continued use of the same amount of the substance,  
• Withdrawal as manifested by the characteristic withdrawal syndrome for the substance, 
or by the ingestion of the same (or a closely related) to relieve or avoid withdrawal 
symptoms, 
• Taking of the substance in larger amounts, or over a longer period, than was intended,  
• Persistent desire or unsuccessful efforts to cut down or control substance use,  
• Spending a great deal of time in activities to obtain the substance, use the substance, or 
recover from its effects,  
• Reduction or abstinence of important social, occupational, or recreational activities 
because of substance use,  
• Continued substance use despite knowledge of having a persistent or recurrent 
physical or psychological problem that is likely to have been caused or exacerbated by 
the substance (APA, 2000). 
Substance Abuse is described as a maladaptive use of chemical substance(s) leading to 
clinically significant outcomes or distress (i.e.. recurrent legal problems, failure to perform at 
work/home/school, and physically hazardous behaviour). The criteria do not include 
tolerance, withdrawal, or a pattern of compulsive use. Instead it includes the harmful 
consequences of repeated use. It is pre-empted by the diagnosis of Substance Dependence at 
any point in the individual’s life, and for that specific class (or classes) of substances. 
Substance Abuse is manifested by one (or more) of the following occurring within a 12-
month period:  
• Recurrent substance use resulting in a failure to fulfill major role obligations at work, 
school, or home (e.g., repeated absences or poor work performance related to substance 
use; suspensions from school; neglect of children),  
• Recurrent substance use in situations in which it is physically hazardous (e.g., driving 
an automobile impaired by substance use),  
• Recurrent substance-related legal problems (e.g., arrests for substance-related 
disorderly conduct),  
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• Continued substance use despite having persistent or recurrent social or interpersonal 
problems caused or exacerbated by the effects of the substance (e.g., arguments with 
spouse about consequences of intoxication) (APA, 2000).  
It has been proposed that the substance use disorders will have different criteria in the 
upcoming American Psychiatric Association DSM-5. Under the new classification of 
Substance Use and Addictive Disorders, the proposed revision collapses the existing 
division between dependence and abuse, and lists the existing indicators together (for a total 
of 11 indicators). Severity of the disorder will be described as moderate with the presence of 
2-3 positive criteria and severe for 4 or more positive criteria. The term ‘Physiological 
Dependence’ will refer to evidence of tolerance and/or withdrawal (American Psychiatric 
Association [APA], 2011). 
Individuals in the ‘pedestal professions’ are also potentially vulnerable to developing 
substance dependence or substance abuse, and some health care professionals will be 
affected regardless of any special knowledge, skills, or insights they may have due to their 
education and professional experience. The health care professional might have entered 
their career with a family history of members with these disorders or other vulnerabilities 
that place them at risk (Kenna & Wood, 2005). There is evidence suggesting health care 
professionals may be placed at increased risk for developing these disorders because of 
work related factors such as high job strain, disruption and fatigue related to shift work and 
long hours, ease of access to medications in the workplace, self-treatment of pain and 
emotional problems, working in certain specialties, and knowledge of the benefits of 
medications (Lillibridge et al., 2002; McAuliffe et al., 1987; Trinkoff & Storr, 1998; Trinkoff et 
al., 2000; Wright, 1990).  
Since the late 1970’s, numerous studies have examined the use of substances among health 
care professionals. Methodological inconsistencies between these studies do not allow for 
direct comparisons or conclusions. In general, however, it appears that health care 
professionals are affected at rates similar to the general population with possibly higher 
patterns of use for substances they may have access to within the workplace (Brewster, 1986; 
Collins, 1999; Hughes et al., 1992; Kenna & Wood, 2004; Kunyk, 2011; Storr et al., 2000; 
Trinkoff & Storr, 1998; Tyssen, 2007). If this conclusion is accurate, then approximately 8.5% 
of health care professionals will have an alcohol use disorder (Hasin et al., 2007), and a 
further 2% (Compton et al., 2007) will experience a drug use disorder within the next 12 
months.  
3. Mitigation of risk 
Substance use disorders within the health care professions is a serious and complex issue for 
the individual with the disease as well as their families, patients, colleagues, professional 
body, employer, and society at large. The health of the health care professional is threatened 
as these disorders typically progress in severity and may result in premature death (Kleber 
et al., 2006). Health care professionals are in a safety-sensitive positions; their occupational 
functioning impacts public safety. Patient safety may be placed at risk when health 
providers practice with active, untreated substance use disorders as alertness, attention, 
concentration, reaction time, coordination, memory, multi-tasking abilities, perception, 
thought processing, and judgment can be compromised (Graham et al., 2003).  
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When substance use disorders are expressed in health care professionals, the goal is for 
early identification, treatment, documentation, and monitoring of ongoing recovery prior to 
the illness impacting the care of patients or the health of the health care provider with the 
disorder. Achieving this goal also reduces the risks of these disorders to the health of the 
health care professional. The global and chronic shortage of health care professionals (World 
Health Organization [WHO], 2006) confirms that early identification, recovery, and return to 
work are critical goals for society. As a group, however, health care professionals often 
ignore our collective responsibility for identifying, treating, and supporting our colleagues 
when a substance use disorder comes to expression (Talbot & Wilson, 2005). 
3.1 Early Identification 
Early identification of health care professionals affected by substance use is necessary to 
protect the safety of patients and to achieve the best possible outcomes for the health of the 
health provider. This is a challenging goal as early evidence of the disease may be difficult 
to identify. Research suggests that the order in which the effects of substance use disorders 
in physicians are first observed starts with the family, then the community, next is financial, 
spiritual, emotional and physical health, after which job performance is finally impacted 
(Talbott & Wilson, 2003). 
As the work area is the last place where substance use by the health care professional is 
apparent, identification may occur late in the progression of the Substance Use Disorder. 
Identification of concerns about the use of substances by a health care professional on their 
practice, or on their health, may be self-identified, identified by their colleagues or through a 
formal complaint to the employer or regulatory body. These will now be discussed. 
3.1.1 Self-identification 
Health care professionals are ethically required to ensure their fitness to practice by 
withdrawing, restricting, or accommodating their practice if unable to safely perform essential 
functions of their role. This responsibility can be interpreted to necessitate self-removal from 
the work setting if the health care professional questions his/her use of alcohol and/or drugs. 
For the purposes of ongoing registration, health care professionals may be required to self-
identify whether the use of alcohol and/or other drugs may impair their ability to practice 
upon their initial registration as well as on their annual practice permit application.  
There is some evidence to suggest that nurses may be more cognizant of the need to access 
treatment for their substance use, and more engaged in treatment, when compared with the 
general population. Within a sample of 129 registered nurses self-identified with substance 
dependence in the last 12 months, 27 (22.3%) had sought help for their use of alcohol and/or 
drugs within the last 12 months. Slightly more (28; 23.2%) thought they should seek help but 
had not done so. Most of this subset (23; 82.0%) indicated they did not get help because they 
were too embarrassed to discuss it with anyone. The next most cited reason (18; 53.2%) was 
they did not think anyone could help (Kunyk, 2011). That almost one quarter of nurses with 
substance dependence were receiving some help is a positive finding. As almost one quarter 
aware of their need for assistance with their alcohol and/or drug use but had not done so 
suggests there is a tremendous opportunity to mitigate the risks associated with substance 
use.  
Reducing the barriers to self-identification and treatment seeking is one measure to mitigate 
risks associated with substance use disorders in the health care professions. Stigma is a key 
www.intechopen.com
 
Health Care Under the Influence: Substance Use Disorders in the Health Professions 
 
431 
barrier for anyone impacted by the substance use disorders. Stigma is not confined to the 
general public; it also occurs among health professionals (Standing Senate Committee on 
Social Affairs, 2006). Some nurses have acknowledged delaying treatment seeking because 
of stigma felt within the workplace, and this procrastination prolonged their recovery 
(Lillibridge et al., 2002). Darbro (2005, p.179) noted that a ‘culture of mistreatment of addicts 
in the workplace by health care professionals’ was listed as a reason for concealing their 
illness from colleagues, and that this procrastination prolonged their recovery. In this sense, 
the environment in which the health care professional works can be a part of the problem. 
Confidentiality provides a level of protection from stigma and, for this reason, is considered 
an essential precondition to successful treatment for individuals with substance use 
disorders (Roberts & Dyer, 2004). Confidentiality may be placed at risk when health care 
professionals with substance use disorders seek treatment when their employer is also their 
health care professional. Confidentiality is also not afforded when health care professionals 
are subject to formal investigations, open hearing tribunals, and publication of discipline 
decisions.  
“Wearing Two Hats”:  When the Employer is the Treatment Provider 
 
In some situations, health care professionals may be placed in the position of receiving 
treatment from their employer for their substance use disorder. As the substance use 
disorders are highly stigmatizing illnesses, confidentiality by the treatment provider is a 
critical necessity for the individual seeking treatment. However, the employer is also 
responsible for assuring the provision of safe care by their employees. What are the 
responsibilities when a treatment provider learns that their health care professional-
employee has a substance use disorder? 
 
The Alberta Office of the Information and Privacy Commissioner (Order H2011-001) 
made a ruling on this question when a complaint was lodged against Alberta Health 
Services’ (AHS) collection, use, and disclosure of the health information of an employee 
with a substance use disorder. In this case, the health care professional (an employee of 
AHS) attended addiction counseling through AHS Mental Health and Addiction 
Services. The counselor provided the information obtained to the AHS human resources 
department. This information was then used to conduct an investigation that resulted in 
suspension from employment. The health information was also disclosed to the 
regulator/professional body. 
 
In examining the case, the Adjudicator raised a number of important questions and 
conclusions: 
• Why would subjecting an individual to a human resource investigation be necessary 
for promoting and protecting the public health (Section 52), 
• Why would an employee receiving treatment for a relapse pose a threat to public 
health (Section 530), 
• Disciplining health professionals rather than treating them is not in the best interests 
of either health care professionals or their patients given the risk that health care 
professionals will not seek treatment to avoid professional repercussions. To better 
protect patients, the privacy of health care professionals should be protected. Patient 
confidentiality is key to providing reasonable healthcare. Employees/health care 
www.intechopen.com
 
Mental Illnesses – Evaluation, Treatments and Implications 
 
432 
professionals are entitled to the same level of reasonable health care (and 
confidentiality) as other Albertans (Section 59), 
• There is nothing in the Health Information Act that suggests that patients who are 
also health care professionals should have less protection in relation to their health 
information than anyone else seeking health services has (Section 71), and 
• The AHS interpretation would have ‘the extremely deleterious chilling effect of 
discouraging health care professionals with health problems which could be seen as adversely 
affecting their ability to perform their employment duty from seeking treatment in order to 
avoid these problems from coming to light. This approach would have the effect of 
exacerbating the problems to patient care that the provision is seeking to avoid (Section 72).’ 
The Arbitrator concluded that when individually identifying health information was 
transferred between the addictions counselor and the acting manager and employees of 
human resources for the purpose of conducting a human resources investigation, this was 
an internal use of health information, and that the disclosure of health information and 
also that the professional body contravened the Health Information Act. The employer 
was ordered to cease collecting, using and disclosing health information in contravention 
of the Health Information Act.  
 
This decision provides clarification regarding the protection of confidentiality for the 
health care professional who is receiving treatment, and the boundaries between the role 
of treatment provider and employer. It is consistent with the American Medical 
Association (2008) statement that ‘as patients, physicians are entitled to the same right to 
privacy and confidentiality of personal medical information as any other patient’. 
 
Source: Alberta, Office of the Information and Privacy Commissioner, Order H2011-001, July 
29, 2011, Alberta Health Services, Case File Number H3350 (www.oipc.ab.ca) 
3.1.2 Peer identification  
Perhaps one of the more difficult challenges health care professionals may have to confront 
in their careers is to determine their obligations when they suspect substance use is affecting 
the performance of a colleague. Taking action may feel overwhelming when faced with 
uncertainty about how to proceed, the knowledge that raising concerns in such situations is 
often difficult at best, and the awareness that any action may permanently risk the 
reputation of the colleague under concern. There is also the reality that the health care 
professionals involved in this situation may continue to work together and that action (or 
inaction) will impact on their ongoing relationship.  
Health care professionals are morally, and often legally, compelled to address threats to the 
delivery of safe, competent, compassionate, and ethical care, as may be the case when the 
practice of their colleagues may be impaired by the use of substances. Moral obligations are 
also raised when health care professionals develop substance use disorders, as they would 
be for any other health care professional with an illness, but particularly when the high 
stress of caring work and access to substances has placed them at risk (Kunyk & Austin, 
2011). For any health care professional having concerns about a colleague, their professional 
and ethical requirement is to report these. 
The urgency of patient safety in the immediate situation is clearly of utmost priority and 
health care professionals are obliged to intervene when they perceive patient risk. If harm is 
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not imminent, health care professionals are obligated to address their concerns as directly as 
possible in ways that are consistent with the good of all parties. When appropriate and 
feasible, actions may include: 
• Directly seek input from the colleague whose behaviour or practice has raised concern,   
• Maintaining a high level of confidentiality about the situation and actions, 
• Seek information from relevant authorities (e.g. supervisor or manager) on expected 
roles and responsibilities for all of the parties, and 
• Consult the relevant professional association and/or regulatory body for guidance 
and/or to assist in addressing and resolving the problem. 
With these initial steps, the colleague may be approached, and advice and direction sought, 
without revealing the identity of the colleague with the suspected problem (Canadian 
Nurses Association [CNA], 2008, p. 41).  
There are members of the health care community who do not believe they have the able to 
recognize or to assist when the practice of a colleague may be impaired by the presence of 
an active and untreated substance use disorder. In an Internet survey of 4064 registered 
nurses, 98% nurses understood the importance of identifying impaired practice. But only 
53% were confident in their abilities to recognize or intervene when it occurs (Kunyk, 2011). 
Health care professionals must learn about, and become sensitive to, signs of substance use 
affecting the professional performance of their colleagues. As the substance use disorders 
are potentially fatal, and impaired practice places patient care at risk, early detection may 
save their colleagues’ or a patients’ life.  
The manifestations of impaired practice tend to be varied and non-specific. Early on, 
patterns of high alcohol intake at social events or generalized irritability might be observed. 
Later they may be as overt as intoxication, with symptoms of ataxia and dysarthia, while at 
work (Berge et al., 2009). Behaviours associated with physicians might include late rounds, 
unavailability or inappropriate responses to calls, and prolonged or failure to respond to 
paging (Talbott & Wilson, 2003). It has been noted that nurses may volunteer to give pain 
relief to their colleagues patients, wait until alone in the medication room before opening the 
narcotics cabinet, and consistently sign out more narcotics that their peers (Quinlan, 2003). 
When the substance of choice is diverted from the workplace, the health provider may show 
up at work when not scheduled or work longer hours. For health care professionals, alcohol 
is the most common drug of choice followed by opioids, and multiple drug use is not 
uncommon (Glasser et al., 1986. Gossop et al., 2001; Reading, 1992). Berge, Seppela and 
Schipper (2009) have identified specific behaviours suggestive of alcohol dependence and 
opiate dependence in health care professionals (Table 1). 
When concerns about substance use on their professional practice are addressed, the health 
care professional may reject the possibility. Others may be relieved that they were 
approached. The identification of the problem by a nurse colleague can be the turning point 
for recovery (Lillibridge et al., 2002). Recovered nurses have reported that they felt let down 
when other nurses failed to recognize or confront their substance problem, and some 
recovered colleagues feel that the intervention probably saved their lives (Lillibridge et al., 
2002). In fact, having the support of colleagues is perceived as one of the most important 
factors in a successful recovery (Hughes, 1998). 
When addressing concerns, the objectives are for the health care professional to immediately 
discontinue work and directly proceed to have a comprehensive assessment to determine 
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the presence of a substance use disorder. With a compassionate, non-confrontational 
approach, an assessment and discontinuation of work is strongly advised because concerns 
have arisen without pressing the issue of whether or not there is a bona fide problem. If this 
is refused, then the individual is advised that the alternative is to refer the matter to the 
regulatory board (Skipper, 2009). Referral options and an action plan should be in place so 
that the health care professional-patient will be enabled to follow the recommended 
assessment and/or treatment. Arguments have been made for a chain-of-custody transfer of 
the health care professional-patient to the area where the assessment will occur to decrease 
the risk of a tragic outcome (Berge et al., 2009). 
 
 Signs Suggestive of Alcohol Dependence  
• Alcohol on breath 
• Slurred speech 
• Ataxia 
• Erratic performance or decrement in performance 
• Tremulousness 
• ‘Out of control’ behavior at social events 
• Problems with law enforcement 
• Hidden bottles 
• Poor personal hygiene 
• Failure to remember events, conversations or commitments 
• Tardiness 
• Frequent hangovers 
• Poor early morning performance 
• Unexplained absences 
• Unusual traumatic injuries 
• Mood swings 
• Irritability 
• Sweating 
• Domestic/marital problems 
• Isolation 
• Leaving the workplace early on a regular basis 
Signs Suggestive of Opioid Dependence  
• Periods of agitation (withdrawal) alternating with calm (drug was just taken) 
• Dilated pupils (withdrawal) or pinpoint pupils (side effect of opiate) 
• Excessive sweating 
• Wearing long sleeves 
• Frequent bathroom breaks 
• Unexplained absences during the workday 
• Spending more hours at work than necessary 
• Volunteering for extra call / work 
• Volunteering to provide extra breaks or refusing breaks 
• Volunteering to clean operating rooms 
• Volunteering to return waste drugs to pharmacy
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• Rummaging in sharps container 
• Slopping record keeping or discrepancies between charted dose and actual dose 
delivered 
• Excessive narcotic use charted for patients 
• Assay of waste drug returned showing evidence of dilution 
• Never returning any waster at the end of a case 
• Patients reporting pain out of proportion to charted narcotic dose
Source: Berge, K.H., Seppela, M.D., Schipper, A.M. (2009). Chemical dependency and the physician. 
Mayo Clinical Proceedings 84(7): 625-631. 
Table 1. Possible Signs Suggestive of Substance Dependence in a Health Care Professional 
3.1.3 Formal complaint 
Both health organizations and regulatory bodies have responsibilities to ensure their 
patients are receiving safe and ethical care. For regulatory bodies, their mandate is to assure 
their members are practicing according to their professional standards. But there are also 
organizational responsibilities to health care professionals with substance use disorders. 
Human rights legislation in Canada recognizes addiction as a disability. As a result, there 
exists a duty to accommodate for both the employer and the regulator. Health care 
professionals with substance use disorders may come to the attention of their regulator 
and/or employer through formal complaints filed by colleagues, public members, or other 
individuals. When this occurs, these organizations are required to respond according to 
their policy directions. 
Their options for action will be discussed in section 4.0 on policy alternatives. 
3.2 Comprehensive assessment 
When concerns about the effects of substance use are identified, the objectives are for 
immediate withdrawal from practice until a comprehensive assessment may take place. The 
purpose of this assessment is to establish whether or not the individual has a substance use 
disorder. One or more medical professionals experienced in the evaluation of substance use 
disorders and its concomitant problems in health care professionals may perform the 
assessment (Talbott & Earley, 2003). Certified addiction medicine specialists (American 
Board of Addiction Medicine [ABAM], 2011) are trained to identify and treat the medical 
consequences of alcohol and / or substance abuse. These specialists perform a detailed 
history and examination, and order the appropriate diagnostic and confirmatory testing, to 
determine the medical diagnosis and recommendations for a range of addiction medicine 
treatments.  
An assessment can determine, with a reasonable degree of medical certainty, if the health 
professional in question is impaired1 or potentially impaired because of their use of alcohol 
and/or other substances. A comprehensive assessment should also determine any 
coexisting physical or mental problems, and make recommendations for the individual’s 
treatment needs. The assessment team must also determine whether issues involving public 
                                                 
1 The American Medical Association [AMA] Guides to the evaluation of Permanent Impairment, Sixth 
Ediction (2011) refers to impairment as ‘a significant deviation, loss, or loss of use of any body structure or 
body function in an individual with a health condition, disorder, or disease’. 
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health and safety, or violations of ethical standards, require that the health care professional 
be reported to their regulatory body, if not already aware (Talbott & Earley, 2003).  
With a positive diagnosis for a substance use disorder, the first ethical obligation of the 
health care professional is to remove himself/herself from practice and engage in treatment. 
Many regulators have a requirement that the member self-report when they have an illness 
that may possibly impair their ability to practice.  
3.3 Detoxification, medical stabilization and treatment 
The Substance Use Disorders are widely considered to be amenable to treatment. The 
outcomes to evidence-based interventions are similar to other chronic disease conditions 
including hypertension, asthma, and Type 2 diabetes (McLellan et al., 2000). Most persons 
with a substance use disorder will have one or more relapses (the return to substance use 
after a drug-free period) during their ongoing process of recovery.  
Early intervention with tailored, multi-modal and long-term treatment is generally 
acknowledged as providing the most beneficial treatment outcomes. These outcomes may 
include abstinence from, or reduction in, the use of substances, reduction in the frequency 
and severity of relapse to substance use, improvement in psychological and social 
functioning, and increased life expectancy (Kleber et al., 2006). For health care professionals, 
the primary goal is to achieve abstinence and maintain long-term remission of his or her 
substance use disorder (Talbot & Wilson, 2003). 
Comprehensive treatment is aimed at reducing denial, increasing self-care, treating the 
coexisting family, medical, and psychiatric problems, and helping the health care 
professional learn to protect himself/herself from the substance use disorder. Safe and 
effective evidence-based treatments for individuals with substance use disorders requires 
matching treatment to include the modalities available for the particular disorder and 
comorbidities, as well as follow-up on a longitudinal basis. Evidence-based treatments for 
these disorders recognize their chronic and relapsing nature, and this frames recovery as a 
process as opposed to an event. With this approach, stand-alone interventions such as 
detoxification and residential treatment are considered as only one component to 
comprehensive treatment. The National Institute on Drug Abuse [NIDA] has identified 
thirteen principles for addiction treatment (Table 2). 
Comprehensive treatment often includes detoxification, medical stabilization, individual and 
group therapy, Twelve Step programs, medication as required, written assignments, 
psychoeducation, family education and therapy, and workplace/lifestyle restructuring. A 
longitudinal approach to management of this chronic disease is ideal and, in general, the 
iterative goals of treatment are first to engage, assess, motivate, and help to retain the health 
care professional-patient in a safe and effective evidence-based treatment setting. Treatment 
retention and adherence to mutually agreed-upon goals generally maximize potential benefits 
of treatment and improve outcomes (Kunyk, Els & Robinson Hughes, 2010).  
 
1. Addiction is a complex but treatable disease that affects brain function and 
behavior. Drugs of abuse alter the brain's structure and function, resulting in 
changes that persist long after drug use has ceased. This may explain why drug 
abusers are at risk for relapse even after long periods of abstinence and despite the 
potentially devastating consequences. 
2. No single treatment is appropriate for everyone. Matching treatment settings, 
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interventions, and services to an individual's particular problems and needs is critical 
to his or her ultimate success in returning to productive functioning in the family, 
workplace, and society. 
3. Treatment needs to be readily available. Because drug-addicted individuals may be 
uncertain about entering treatment, taking advantage of available services the 
moment people are ready for treatment is critical. Potential patients can be lost if 
treatment is not immediately available or readily accessible. As with other chronic 
diseases, the earlier treatment is offered in the disease process, the greater the 
likelihood of positive outcomes. 
4. Effective treatment attends to multiple needs of the individual, not just his or her 
drug abuse. To be effective, treatment must address the individual's drug abuse and 
any associated medical, psychological, social, vocational, and legal problems. It is 
also important that treatment be appropriate to the individual's age, gender, 
ethnicity, and culture. 
5. Remaining in treatment for an adequate period of time is critical. The appropriate 
duration for an individual depends on the type and degree of his or her problems 
and needs. Research indicates that most addicted individuals need at least 3 months 
in treatment to significantly reduce or stop their drug use and that the best outcomes 
occur with longer durations of treatment. Recovery from drug addiction is a 
longterm process and frequently requires multiple episodes of treatment. As with 
other chronic illnesses, relapses to drug abuse can occur and should signal a need for 
treatment to be reinstated or adjusted. Because individuals often leave treatment 
prematurely, programs should include strategies to engage and keep patients in 
treatment. 
6. Counseling—individual and/or group—and other behavioral therapies are the 
most commonly used forms of drug abuse treatment. Behavioral therapies vary in 
their focus and may involve addressing a patient's motivation to change, providing 
incentives for abstinence, building skills to resist drug use, replacing drug-using 
activities with constructive and rewarding activities, improving problemsolving 
skills, and facilitating better interpersonal relationships. Also, participation in group 
therapy and other peer support programs during and following treatment can help 
maintain abstinence. 
7. Medications are an important element of treatment for many patients, especially 
when combined with counseling and other behavioral therapies. For example, 
methadone and buprenorphine are effective in helping individuals addicted to 
heroin or other opioids stabilize their lives and reduce their illicit drug use. 
Naltrexone is also an effective medication for some opioid-addicted individuals and 
some patients with alcohol dependence. Other medications for alcohol dependence 
include acamprosate, disulfiram, and topiramate. For persons addicted to nicotine, a 
nicotine replacement product (such as patches, gum, or lozenges) or an oral 
medication (such as bupropion or varenicline) can be an effective component of 
treatment when part of a comprehensive behavioral treatment program. 
8. An individual's treatment and services plan must be assessed continually and 
modified as necessary to ensure that it meets his or her changing needs. A patient 
may require varying combinations of services and treatment components during the 
course of treatment and recovery. In addition to counseling or psychotherapy, a 
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patient may require medication, medical services, family therapy, parenting 
instruction, vocational rehabilitation, and/or social and legal services. For many 
patients, a continuing care approach provides the best results, with the treatment 
intensity varying according to a person's changing needs 
9. Many drug-addicted individuals also have other mental disorders. Because drug 
abuse and addiction—both of which are mental disorders—often co-occur with other 
mental illnesses, patients presenting with one condition should be assessed for the 
other(s). And when these problems co-occur, treatment should address both (or all), 
including the use of medications as appropriate. 
10. Medically assisted detoxification is only the first stage of addiction treatment and 
by itself does little to change long-term drug abuse. Although medically assisted 
detoxification can safely manage the acute physical symptoms of withdrawal and, 
for some, can pave the way for effective long-term addiction treatment, 
detoxification alone is rarely sufficient to help addicted individuals achieve long-
term abstinence. Thus, patients should be encouraged to continue drug treatment 
following detoxification. Motivational enhancement and incentive strategies, begun 
at initial patient intake, can improve treatment engagement. 
11. Treatment does not need to be voluntary to be effective. Sanctions or enticements 
from family, employment settings, and/or the criminal justice system can 
significantly increase treatment entry, retention rates, and the ultimate success of 
drug treatment interventions 
12. Drug use during treatment must be monitored continuously, as lapses during 
treatment do occur. Knowing their drug use is being monitored can be a powerful 
incentive for patients and can help them withstand urges to use drugs. Monitoring 
also provides an early indication of a return to drug use, signaling a possible need to 
adjust an individual's treatment plan to better meet his or her needs 
13. Treatment programs should assess patients for the presence of HIV/ AIDS, 
hepatitis B and C, tuberculosis, and other infectious diseases as well as provide 
targeted risk-reduction counseling to help patients modify or change behaviors 
that place them at risk of contracting or spreading infectious diseases. Typically, 
drug abuse treatment addresses some of the drug-related behaviors that put people 
at risk of infectious diseases. Targeted counseling specifically focused on reducing 
infectious disease risk can help patients further reduce or avoid substance-related 
and other high-risk behaviors. Counseling can also help those who are already 
infected to manage their illness. Moreover, engaging in substance abuse treatment 
can facilitate adherence to other medical treatments. Patients may be reluctant to 
accept screening for HIV (and other infectious diseases); therefore, it is incumbent 
upon treatment providers to encourage and support HIV screening and inform 
patients that highly active antiretroviral therapy (HAART) has proven effective in 
combating HIV, including among drug-abusing populations. 
 
From National Institute on Drug Abuse [NIDA]. (revised April 2009). Available at: 
http://www.drugabuse.gov/PODAT/PODATIndex.html  
 
 
Table 2. Principles of Addiction Treatment 
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3.4 Continuing care 
As the substance use disorders are conceptualized as chronic diseases, detoxification, 
medical stabilization, and addiction treatments are only the beginning disease management. 
Upon successful completion of residential care, if necessary, and primary treatment, the 
health care professional is challenged with sustaining their recovery while returning to 
work.  
After completion of primary treatment, a comprehensive medical assessment by one or 
more professionals experienced in the evaluation of addiction and its concomitant problems 
in health care professionals can provide an independent opinion regarding the scope of 
continuing care required by the recovering health care professional. Total abstinence is the 
treatment goal and adherence to this goal is assessed repeatedly throughout the ensuring 
prolonged monitoring programs (Section 3.5). Continuing care plans are individualized but 
may include specifics regarding: 
• Abstinence from all drugs of abuse, 
• Frequency of reassessment, 
• Addiction medicine physician, 
• Required therapy,  
• Attendance at mutual help group meetings e.g. Caduceus,  
• Random urine screening with observed micturition, 
• Modifications in practice,  
• Workplace surveillance,  
• Additional continuing care assignments,  
• Protocols to be followed should mood-altering drugs be required for a medical reason, 
• Primary care physician, 
• Family therapy, 
• Contingencies should a relapse to substance use occur, and  
• Names of individuals who will support the health care professional in his or her 
ongoing recovery.  
Not all health care professionals receive similar or optimal treatment programs and return-
to-work options. An exploratory study compared initial clinical presentations, service 
utilization patterns, and post-treatment functioning of physicians and nurses with substance 
use disorders who received services in an addiction treatment program (Shaw et al, 2004). 
Members of both professions showed comparable results. Prior to participating in the 
program, nurses showed less personality disturbance than physicians but did tend to work 
and live in environments with more triggers to relapse. Following their initial 
hospitalization, nurses received less primary treatment, worked longer hours, and were 
more symptomatic than physicians. Furthermore, nurses in this study reported more 
frequent and severe work-related sanctions. The authors conclude that, although in most 
areas of study, nurses and physicians demonstrated comparable results but that these 
significant differences suggest these groups may have different clinical needs. 
3.5 Monitoring programs 
The purpose of monitoring programs are to support the health care professional, monitor 
their success and intervene with difficulties during the recovery period and, in so doing, 
protect the public (FSPHP, 2000). Monitoring programs provide the active case management 
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and supervision system for health care professionals who have signed formal, binding 
contracts for their participation. Health care professionals who refuse to enter into a contract 
agreement are usually reported to their regulator, if not previously aware.  
Monitoring of recovering health care professionals provides a sensitive and specific 
mechanism for ensuring treatment occurs and for early detection of relapse, and may be a 
licensing requirement. Much of the work in the area of monitoring programs has been with 
physicians. There are several designations for these programs such as physician health 
programs, physician aftercare, physician recovery networks, diversion, alternative to 
discipline, impaired physician, and physician health effectiveness programs.  
The Federation of State Physician Health Programs guidelines require long-term monitoring 
of physicians after successful completion of treatment with reporting to the appropriate 
regulatory body any instance of a physician who is not able to cooperate with indicated 
treatment and monitoring or who becomes impaired (FSPHP, 2008). Through their 
experience and research, they have concluded that long-term recovery from the substance 
use disorders are routinely achieved after five years of successful monitored recovery. They 
further recognize that, after 5 years of monitored recovery, physicians usually are successful 
in managing further problems in their recovery through the use of their extensive support 
network while recognizing that some may benefit from shorter or lengthier periods (FSPHP, 
2000).  
Monitoring includes substance use detection and compliance with specifics of the 
monitoring contract plan. With random alcohol and drug testing, participating health care 
professionals call a telephone number daily during the working week to see if they are to be 
tested that day. A computer is used to randomly assign the decision as to who gets tested 
that day. The frequency of testing is more often earlier in the beginning of the contract 
period and less frequent towards the end of the five years.  
When contracted, supervised care and monitoring of the health care professional occurs, 
regulators often defer disciplinary action with the stipulation that evidence of failure to 
adhere or relapse under patient care conditions will lead to referral of the health care 
professional back to the regulator (Dupont et al., 2009). A relapse includes the use of alcohol 
or other drugs non-medically, and also includes failure to adhere to treatment session or 
other signs of noncompliance.  
Monitored care may start with residential or intensive outpatient care in a specially 
treatment program. Health care professionals commonly withdraw from practice at this 
time. The choice of treatment provider may be limited to specific programs with which the 
monitoring program has had extensive, successful experiences, and is known to provide 
excellent care. Monitoring is initiated or continues when the recovering healthcare 
professional moves into continuing care. 
The evidence suggests that physicians have high rates of recovery when involved in long-
term continuing care and monitoring programs. In a five-year, longitudinal cohort study, 
904 physicians in 16 state physician health programs in the United States were followed 
(McLellan, Skipper, Campbell & Dupont, 2007). The outcome measures were program 
completion, alcohol and drug use, and occupational status at five years. Of the 80.7% of 
physicians who had completed treatment and resumed practice under supervision and 
monitoring, alcohol or drug misuse was detected by urine testing in 1.9% over the five 
years. At the five-year follow-up, 78.7% were licensed and working. The authors concluded 
that programs with an appropriate combination of treatment, support, and sanctions to 
manage addiction among physicians are effective.  
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There is evidence to support this model for a range of populations but its implementation is 
not consistent across the health care professions. Talbot (2005), in reiterating his earlier 
work, postulates that the factors that appear to have predictive value in assessing successful 
recovery include: 
• The number of 12-step (or reasonable alternatives) meetings attended per week. 
• A working relationship with a sponsor and frequent sponsor contact. 
• Random drug screening. 
• Monitoring milestones in each stage of recovery. 
• Monitoring for the effects of the emergence of compulsive behaviours. 
• Evaluation of the status of current therapies, treatments, and medications. 
• Assessment of family relationships. 
• Physical health status.  
• Number of leisure activities per week. 
• Compliance with monitoring activities, timely attendance at recommended therapies, 
and 12-step (or reasonable alternatives) meetings. 
• Amount of time spent exercising per week. 
• Evaluation of work-related stressors. 
• Monitoring of changes in financial status. 
• Additional training and/or continuing medical education. 
• Self-rated quality of recovery programs. 
• The identification of the soft parts of the physician-patient recovery program. 
Physicians in continuing care and monitoring programs receive an optimal treatment model 
that assumes primary medical responsibility for the disease. These programs combines 
empathic support with the highest level of structure of close monitoring, and sanctions 
matched according to need. Physicians with substance use disorders treated within this 
framework have the highest long-term recovery rates recorded in the treatment outcome 
literature: between 70% and 96% (Brewster et al., 2008; Domino et al, 2005; Gastfriend, 2005; 
Gold & Aronson, 2005; McLennan et al., 2007; Smith & Smith, 1991, Talbott et al., 1987).  
4. Policy alternatives 
Organizations including employers, regulators, professional associations, and unions are 
obliged to respond when they become aware of their health care professionals whose practice 
may be impaired by use of substances. The purpose of intervening is to protect the public from 
harm and not to punish the health care professional (CNA, 2009). Responsibilities for ensuring 
the provision of safe, ethical care meeting the standards of practice for the profession requires 
the enactment of comprehensive policies. There are two dominant organizational policy 
responses to substance use disorders among the health professions: discipline and alternative 
to discipline. Considerable variation exists within each of these groupings due to legislation, 
structuring of responsibilities, and professional standards. 
In general, disciplinary (punitive) policies are designed to penalize health care professionals 
and prevent them from practicing for the purpose of protecting the public (Monroe, 
Pearson, & Kenaga, 2008). Disciplinary measures include actions such as termination, 
probation, practice restrictions, and suspension or revocation of practice licenses (Corsino, 
Morrow, & Wallace, 1996). Some disciplinary programs may include aftercare, case 
management, and assistance for re-entering the workforce (Quinlan, 1994). 
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In the disciplinary model, upon the receipt of a formal complaint (e.g. pharmaceutical theft 
from the employer, failure to provide analgesics to patients, or falsification of records), a 
formal investigation may be launched. This may incorporate, among other powers, access to 
the health care professionals’ workplace including interviewing colleagues, managers, and 
other individuals connected to the nurse under investigation (Health Professions Act, 2000, 
section 63). If supported by sufficient evidence, the complaint proceeds to an open hearing 
tribunal that may include a lawyer representing the regulator, another for the health care 
professional in question, and an independent counsel to advise the tribunal panel members 
of peers. When the health care professional in question is found guilty of unprofessional 
conduct, sanctions vary but may include: 
• A reprimand that the behavior falls below the expected standards for practice, 
• Loss of licensure, 
• Suspension, 
• Restrictions on the practice permit, 
• Requirement of supervised practice, 
• Ongoing documentation of specified treatment modalities, 
• Random drug screening, and 
• Publication of the discipline decision with identification of the health care professional 
by name or license number. 
It has been estimated that the process of investigation followed by a formal hearing to 
determine disciplinary action may take from eight months to three years for resolution and, 
as the focus is on discipline, there is little attempt to advocate for the individual, provide 
treatment or rehabilitation services, or follow outcomes (Sullivan, Bissell, & Leffler, 1990). 
With alternative to discipline responses, when there is reason to believe that the use of 
substances are affecting professional performance, the authority (e.g. employer or regulator) 
requires the health care professional to submit to specified physical and/or mental 
examinations and withdrawal from providing professional services pending the report. If 
the presence of an illness is determined (e.g. a substance use disorder), the authority would 
direct the health care professional to engage in treatment until their addiction treatment 
team determines readiness to return to work. If the examination does not detect the presence 
of an illness, the authority may choose to instigate a formal investigation and, when 
warranted, an open hearing before a tribunal of peers to determine a decision (Health 
Professions Act, 2000). 
Alternative to discipline policies focus on early detection of illness, provisions for adequate 
treatment, and re-entry to practice without prejudice along with measures to protect the 
public (Monroe et al., 2008). These objective are achieved through: 
• A focus on rehabilitation,  
• Protection from public disclosure,  
• Disclosure to the employer, and  
• Long-term monitoring (aftercare) programs upon return to work.  
Alternative to discipline policies provide a mechanism for impaired health care 
professionals to be moved into treatment within hours or days of detection (Monroe et al., 
2008). Long-term monitoring reduces risk to patient safety through early detection of relapse 
while provide support and affording confidentiality and dignity for the health care 
professional in recovery. 
Regardless of the policy approach taken, both the regulator and the employer have the duty 
to accommodate the individual with a diagnosed substance use disorder. 
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Comparisons between discipline and alternative policies are complicated by the degree of 
variation in the approach, time required for treatment and aftercare, and definitions of 
success. In a review of comparisons of discipline and alternative to discipline approaches 
among nurses, it was concluded that alternative to discipline seems to be more 
compassionate and caring about the welfare, treatment, and recovery of nurses as well as 
being more effective at retaining nurses in the profession (Monroe et al., 2008). Furthermore, 
the typical cost savings for aftercare programs are considered substantial compared with the 
costs of investigation and disciplinary action (Darbro, 2003). Some contend that a non-
disciplinary atmosphere of support might be a life-saving first step for nurses with 
substance use disorders as well as for those in their care (Monroe & Kenaga, 2011).  
The policy approach has been noted to impact other nurses in their responsibilities 
regarding their nurse-colleagues with substance use disorders. Hood and Duphorne (1995) 
examined the reporting strategies used by nurses confronted with making the decision to 
report substance abuse among their peers. Nurses who believed that reporting would result 
in punitive consequences were deterred from making formal reports when they suspected 
nurse-colleagues of impaired practice, while nurses who believed that rehabilitative 
consequences would result were more likely to report them. As nurses are the primary 
source of identification of the problem of substance abuse by their colleagues (Monohan, 
2003), the policy approach to nurses with substance use disorders has salience for early 
detection. 
When substance use disorders occur amongst health care professionals, the goals are to 
protect the public from possible harm and to engage the individual health care professional 
into treatment. Fear of disciplinary action is an obstacle for the ill health care professional 
seeking care and a disincentive for reporting by their concerned peers. This raises questions 
about the effectiveness of disciplinary environments in identifying and monitoring their 
health care professionals with substance use disorders. When early referrals are not made, 
health care professionals with substance use disorders often remain without treatment until 
overt impairment is manifest in the workplace (FSPHP, 2008). After noting their members 
with addiction were not receiving the same opportunities for treatment as the general public 
because they were held to a different, disciplinary standard, the American Medical 
Association and the American Nursing Association advocated for non-public, alternative to 
discipline responses (Quinlan, 2003). 
There are counterarguments to the alternative to discipline focus on rehabilitation, 
monitoring and confidentiality. Some jurisdictions with disciplinary responses have 
identified their reluctance to incur expenses involved with monitoring programs (Monroe et 
al., 2008). There are disciplinary jurisdictions that spend substantive resources on formal 
investigations and public hearings. A direct comparison of costs between the disciplinary 
and alternative responses does not appear to be available. A review of disciplinary action on 
52,297 registered and licensed practical nurses between 1996 and 2006 in the U.S. 
determined that 24% were for drug-related violations (Kenward, 2008). A ruling in Alberta 
determined the costs of one Hearing to be $70,000 without including staff time or salaries 
(Appendix A). If this contribution is indicative, regulators following disciplinary approaches 
incur substantive financial burdens.  
This conundrum cannot be settled by legislation alone. In Alberta, with health care 
professionals regulated under the same Health Professions Act (Province of Alberta, 2010), 
there are different approaches. In this setting, complaints dispositions for physicians feature 
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a confidential, rehabilitative approach and registered nurses with an open, disciplinary one 
(Els & Kunyk, 2011). 
Regulators and employers are, most likely, not addiction treatment specialists. When they 
impose conditions for treatment and monitoring, these may not be the most appropriate 
ones for unique needs of the health care professional in question. Nor are the addiction 
treatment providers for the health care professional because they are required to advocate 
on behalf of their health care professional patient (Please see the chapter in this textbook, 
‘Workplace Functional Impairment due to Mental Disorders’ by Els, Kunyk, Hoffman & 
Wargon). In neither of these conditions, is there an external body to evaluate the quality 
of care delivery.  
Concerns about the quality of treatment, and the neutrality of return to work decisions, can 
be addressed by the introduction of a neutral and independent intermediary. A neutral 
body with experts in addiction medicine can provide independent medical assessments, and 
determine the necessary treatments, continuing care, and conditions for return to work. This 
neutral body can also monitor that these conditions are met, and notify regulators and/or 
employers when they are not. An ‘arms length’ relationship between the treatment 
providers and the monitoring program appears to be important. If there is slippage in the 
performance of a particular treatment program or other service provider, it can be removed 
from the list of approved providers (Dupont et al., 2009). 
Case Scenario: Lost Opportunities for Monitoring in a Disciplinary Environment 
Outcome studies on physicians engaged in long-term monitoring programs demonstrate 
the effectiveness of this approach in maintaining recovery, supporting return to work, 
ensuring ongoing treatment, and providing for early detection of relapse. Due to the success 
of this model, the goal must be to ensure that recovering health care professionals with 
substance use disorders are directed into similar programs. When an employer or regulator 
becomes aware of their employees/members with addiction, they have the authority to 
ensure that compliance with continuing care and monitoring programs occurs. 
Fear of disciplinary action is an obstacle for the ill health care professional seeking care 
and a disincentive for reporting by their concerned peers. This raises questions about the 
effectiveness of disciplinary environments in identifying when their health care 
professionals practice while impaired by the use of substances. 
 
The province of Alberta, Canada provides a unique opportunity for study as the 
registered nurses belong to one provincial regulator, and one health authority provides 
most of their employment. Complaints received by the regulator regarding behaviours 
related to substance use are handled through formal investigations (CARNA, 2008a) and, 
if supported by sufficient evidence, the complaint proceeds to an open hearing tribunal. 
When the nurse in question is found guilty of unprofessional conduct, sanctions may 
include a reprimand advising that their behaviour falls below the expected standards for 
nursing practice, suspension and/or restrictions on their practice permit, requirement of 
supervised practice, ongoing documentation of specified treatment modalities, random 
drug testing paid for by the nurse in question, conditions required for return to practice, 
and publication of the discipline decision in its newsletter Alberta RN (CARNA, 2008a, p. 
10). The nurse may also be directed to pay a contribution toward the costs of the 
investigation). 
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In a study in Alberta, 100 registered nurses who had self-identified with substance 
dependence in the last 12 months who were currently working in nursing. Within this 
sample, there were 2 nurses who had been reported to their regulator and 3 that were 
known by their employer. This left 95 registered nurses unknown to an authority that 
could have required ongoing monitoring (Kunyk, 2011).  
 
Jurisdictions with disciplinary policies often claim that they are mandated to protect the 
public (Quinlan, 1994) and do not advocate for the health of the health care professional 
(Monroe et al., 2008). This approach may be counterproductive. The findings from this 
study suggest that with a disciplinary approach, the public is minimally protected from 
the risks associated with substance use. A recommendation for future research is to ask a 
similar question in a jurisdiction that follows an alternative to discipline approach. 
 
5. Conclusions 
Substance use disorders among the health care professions is a complex professional and 
occupational health issue. It is one that will likely affect every one of us, either directly or 
indirectly, at some point in our careers. The serious nature of its threats to patient care, 
health care professional health, and our professional image demands that we deal well with 
the issue. 
For the purposes of mitigating such risks, fitting organizational policies need to take into 
consideration the implications of the broader environment in contributing to the situation. 
Effective treatments for health care professionals with substance use disorders include 
provisions for early detection, tailored, multi-modal, effective, affordable and affordable 
interventions. Aftercare programs are considered an essential component as they enhance 
the recovery of affected health professionals while also reducing the risk to the public 
through the early detection of relapse. 
How can we best deal with substance use disorders amongst health care professionals? The 
heterogeneity between jurisdictions, individual situations, social environments, and 
responsibilities suggests that there is not one solution that is appropriate for all and under 
every circumstances. However, the evidence presented in this chapter, particularly the 
mature models employed with physicians in their interventions and aftercare, suggest there 
are some guiding principles for reducing the risks to patient care and to health care 
professional health. These include: 
1. Policy. The substance use disorders will affect some members within the health care 
professions. This inevitability demands that the health professions, and their 
employers, prepare for dealing well with the situation through the development of 
evidence-based policies.  
2. Health values. Following the principle of think globally, act locally, the manner in 
which this issue is understood and dealt with has global implications not only for 
health care professionals but also for the individuals in their care in similar situations. 
Consistency with health values and beliefs will enhance our professions and health care 
organizations in our respective missions. Health values include respect for health care 
professional - patient confidentiality, the recognition of disease conditions, and the need 
for evidence based care. 
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3. Confidentiality. The substance use disorders are highly stigmatizing illnesses. Health 
care professionals should be afforded the same confidentiality that is required for other 
patients.  
4. Chronic disease model. The substance use disorders are chronic, relapsing conditions. 
Their treatment involves a continuum of care and a long-term perspective based on the 
chronic disease model that includes provision for relapse prevention and early 
detection of relapse. Provision for detoxification, medical stabilization and treatment is 
only the beginning of the intervention this chronic, relapsing disease. Continuing care 
with monitoring for five years is advisable. 
5. Evidence-based care. The substance use disorders are highly responsive to multi-
modal, evidence-based treatment based on the needs of the individual. Policy 
development must take into consideration access to comprehensive and high quality 
addiction treatments that incorporate the NIDA Principles of Addiction. Policy 
development must also outline provisions for coverage of care in the same manner as it 
would for other medical conditions. 
6. Comprehensive intervention. The objective for intervention when impaired practice 
occurs is to minimize the risks to patient care and practitioner health through early 
identification, comprehensive assessment, detoxification, medical stabilization and 
treatment, and continuing care with long-term monitoring.  
7. Monitoring programs. Long-term monitoring of recovering health care professionals is 
effective for supporting recovery and protection of the public when relapses happen. 
Monitoring requires a contractual agreement signed by the recovering health care 
professional with provisions for referral to the regulator should a risk of impaired 
practice occur. These monitoring programs are best performed by a party considered 
‘arms length’ and neutral rather than the treatment provider or regulator. 
8. Decision-making. Assessment, treatment and continuing care decisions are best made 
by a health care team specialized in addiction management, and not the regulator or 
employer. 
9. Minimize discipline. Health care professionals who voluntarily seek recommended 
treatments, successfully complete their treatment, and contract to participate in a 
monitoring program should not receive punitive sanctions. This would encourage both 
self and peer identification. 
10. Early identification. Employers and regulators need to create conditions that require 
fitness for duty, and encourage self and peer identification. This would include 
minimizing the use of discipline and ensuring the right of confidentiality. 
11. Environmental change. As the conditions of being a health care professional may have 
contributed to the development of substance use disorders, the environment is also a 
part of the solution. The empirical findings that errors made by health professionals 
reflect system and organizational issues (Baker et al., 2004) may have some transferable 
learning to this situation. A body of research is required to determine aspects of psycho-
dynamically healthy workplaces for the purposes of preventing the expression of 
substance use disorders amongst health care professionals, their early detection, as well 
as for their return to work upon recovery. 
12. Consistent between disciplines. As the standards developed with physicians’ health 
programs have produced the highest documented long-term recovery rates recorded in 
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the treatment outcome literature, these should be the standards for the other health 
professions.  
13. Return to work. Confidentiality is the privilege of the individual with the disease, and 
disclosure must ultimately be a decision they make. The need to know is restricted to 
those necessary to meet the conditions for return to work.  
14. Human rights. The health care professional with a substance use disorders should be 
afforded the same rights and privileges, including the duty to accommodate, as other 
individuals in society. 
In conclusion, when substance use disorders are expressed amongst some members of the 
health care professions, there are serious implications for risk to the public and to the health 
of the health care professional with the disease. There are many unanswered questions 
regarding management of the substance use disorders amongst health care professionals. 
Research is required on transferability of knowledge between the health care professions, 
outcomes of the effectiveness of specific approaches, unique needs of the professions and 
their specialties, and creating conditions to optimize early identification and ongoing 
recovery. The existing evidence supports creating conditions that encourage early 
identification, reduce barriers to treatment, and that include long-term monitoring programs 
provide the best conditions for mitigating the risks resulting from substance use disorders 
amongst the health care professions to patient safety and health care professional health. 
6. Appendix A: CARNA Decision on Registration #62,312 
During the hearing the Tribunal was presented with an exibit (41) detailing the cost in total 
of this hearing up to February 10, 2010 of $63,174.96 with an additional estimate of costs for 
February 26 of $7,275. 
This totalled approximately $70,000. The costs did nit include costs such as staff time or 
salaries. These were out of pocket expenses as detailed in Exhibit 41. These were expenses 
that CARNA had to pay from its resources, which are in effect the resources of the 
membership. 
American Board of Addiction Medicine [ABAM](2011). American Board of Addiction 
Medicine Certification. http://www.abam.net/become-certified 
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